Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

GLP-1 receptor agonists may cause hair loss, but more research is needed.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Targeting the PGI2 pathway may help heal diabetic foot ulcers.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

Dipotassium glycyrrhizinate helps wounds heal faster, especially in the early stages.

The hydrogel effectively treats oral mucositis by reducing oxidative damage and bacterial infection.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

SIG-1451 could be a promising new treatment for atopic dermatitis.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.